Notice of Effectiveness (effect)
2018年12月26日 - 8:02PM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
December 21,
2018
|
|
Accession Number:
|
0001193125-18-348313
|
|
Submission Type:
|
POS AM
|
|
CIK:
|
0001114220
|
|
Company Name:
|
KERYX BIOPHARMACEUTICALS INC
|
|
File Number:
|
333-214513
|
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
過去 株価チャート
から 5 2024 まで 6 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Keryx Biopharmaceuticals, Inc. (delisted) (ナスダック市場): 0 recent articles
その他のKeryx Biopharmaceuticals Incニュース記事